Uncategorized

PALM BEACH GARDENS, Fla., November 3, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that the U.S. Food & Drug Administration (FDA) had cleared Accelus’s 510(k) application for its Remi™ Robotic Navigation System …

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems Read More »

Surgeons in 19 Countries Can Now Take Advantage of FlareHawk’s Minimal Insertion Profile, Multiplanar and Endplate-Conforming Expansion, and Maximum Graft Delivery PALM BEACH GARDENS, Fla., October 18, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced …

Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., October 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that more than 15,000 FlareHawk® multiplanar expandable cages have been implanted in more than 11,000 patients in the United States. “FlareHawk …

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted Read More »

New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., August 15, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care …

Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced Vail-Summit Orthopaedics and Neurosurgery (VSON) as the first ambulatory surgery center (ASC) to acquire the Remi Robotic Navigation System, …

Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System Read More »

CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the closing of a $12 million lead …

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP) Read More »

All New Gallery Lisa Jacobs promoted to serve as Vice President of Sales Jim Fox promoted to East U.S. Vice President of Sales Jay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla., June 13, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption …

Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders Read More »

New offices provide additional resources for clinical education, surgical training, and robotic research and development PALM BEACH GARDENS, Fla., May 26, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the opening of its new robotic …

Accelus Announces Opening of New Facilities in Colorado and California Read More »

PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Toro Lateral (Toro-L) …

Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FlareHawk TiHawk™11 Interbody …

Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System Read More »